Deals Rumor Mill: Bristol-Myers Squibb, Aramco, Abraaj

By Adam Rhodes ( July 5, 2018, 7:12 PM EDT) -- Bristol-Myers Squibb tapped Deutsche Bank and Jefferies to help it sell off its French over-the-counter drugs unit, Reuters reported on Thursday. Citing anonymous sources, the outlet reported that the unit could come with an up to €1. 5 billion ($1. 75 billion) price tag. Expected suitors include fellow drugmakers Mylan, Procter & Gamble and potentially Recordati, Reuters reported. According to the report, European companies backed by private equity firms are also expected to lob bids for the business. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login